1. Home
  2. KEQU vs IKT Comparison

KEQU vs IKT Comparison

Compare KEQU & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEQU
  • IKT
  • Stock Information
  • Founded
  • KEQU 1906
  • IKT 2008
  • Country
  • KEQU United States
  • IKT United States
  • Employees
  • KEQU N/A
  • IKT N/A
  • Industry
  • KEQU Medical Specialities
  • IKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • KEQU Industrials
  • IKT Health Care
  • Exchange
  • KEQU Nasdaq
  • IKT Nasdaq
  • Market Cap
  • KEQU 124.6M
  • IKT 123.7M
  • IPO Year
  • KEQU N/A
  • IKT 2020
  • Fundamental
  • Price
  • KEQU $41.50
  • IKT $1.50
  • Analyst Decision
  • KEQU
  • IKT Buy
  • Analyst Count
  • KEQU 0
  • IKT 2
  • Target Price
  • KEQU N/A
  • IKT $8.00
  • AVG Volume (30 Days)
  • KEQU 12.5K
  • IKT 117.2K
  • Earning Date
  • KEQU 12-10-2025
  • IKT 11-14-2025
  • Dividend Yield
  • KEQU N/A
  • IKT N/A
  • EPS Growth
  • KEQU N/A
  • IKT N/A
  • EPS
  • KEQU 4.13
  • IKT N/A
  • Revenue
  • KEQU $263,183,000.00
  • IKT N/A
  • Revenue This Year
  • KEQU N/A
  • IKT N/A
  • Revenue Next Year
  • KEQU N/A
  • IKT N/A
  • P/E Ratio
  • KEQU $9.79
  • IKT N/A
  • Revenue Growth
  • KEQU 30.09
  • IKT N/A
  • 52 Week Low
  • KEQU $30.33
  • IKT $1.33
  • 52 Week High
  • KEQU $71.33
  • IKT $4.20
  • Technical
  • Relative Strength Index (RSI)
  • KEQU 37.77
  • IKT 44.48
  • Support Level
  • KEQU $43.20
  • IKT $1.33
  • Resistance Level
  • KEQU $42.36
  • IKT $1.72
  • Average True Range (ATR)
  • KEQU 1.50
  • IKT 0.12
  • MACD
  • KEQU 0.01
  • IKT 0.01
  • Stochastic Oscillator
  • KEQU 28.15
  • IKT 37.21

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: